Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Streem nudges open Frontdoor
Rogue Venture Partners-backed Streem has been bought by Frontdoor, which has plans for its augmented reality-based remote home services technology.
Crystal Amber strikes at Allied Minds
Allied Minds' co-CEOs and chairman are under pressure from activist investor Crystal Amber despite having only taking their posts in June 2019.
Acticor conjures up $24.7m series B
The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.
TKH Group finds FocalSpec for acquisition
Industrial and technical products supplier TKH Group has picked up VTT-founded optical confocal imaging sensor company FocalSpec to enhance its portfolio of precision quality control sensors.
Cabaletta captures $74.8m IPO
University of Pennsylvania spinout Cabaletta has gone public after raising $74.8m in an initial public offering on the Nasdaq Global Select Market.
Dukosi charges towards acquisition
KCK has wholly acquired University of Edinburgh spinout Dukosi, which will continue to operate from its Scotland base ahead of a global expansion.
Xandr commissions Duke-backed Clypd
AT&T advertising unit Xandr has bought Clypd, a TV advertising optimisation service that counts Duke University as a shareholder.
Neighborly leaves the municipal precinct
Stanford-backed micro public finance platform Neighborly has paused the payroll in a concerted attempt to restructure the business and avert insolvency.

Other News

Biontech binds itself to public markets
Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
Aprea closes $97.8m IPO
The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.
Apple screens iKinema for acquisition
Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.
Aprea collects $85m in IPO proceeds
Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.
Frequency attracts $84m in IPO
Frequency, a regenerative medicine developer based on MIT and Harvard research, priced shares at the bottom of its range to raise $84m in its IPO.
Infineon lands Dice
Infineon Technologies Austria has bought its portfolio company Dice, a Johannes Kepler University spinout that produces integrated circuits for radar-powered sensors.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg